The Europe Bone Void Fillers Market would witness market growth of 7.5% CAGR during the forecast period (2023-2030).
Inorganic biomaterials called bioceramics, like bioactive glass and calcium phosphate bioceramics, are used in dentistry as bone void fillers. Due to their bioactivity, potential osteoinductivity, osteoconductivity, hydrophilicity, ease of availability, high biocompatibility, and similarity to natural bone inorganic components, bioceramics are gaining increased interest in dental reconstruction. These properties of bio-ceramics are anticipated to boost demand for dental bone void filling materials and stimulate market expansion.
The dental industry has lately used technological innovations, including 3D scaffolds of bone graft alternatives, to address the shortcomings of commonly used grafting materials. By using scaffolds with a three-dimensional architecture that closely replicate the natural extracellular matrix, bone tissue engineering has created a new technique for regeneration. This configuration eventually improves cell proliferation, adhesion, and total tissue regeneration. The market is driven by this application and the features of cutting-edge technology.
The elderly population is rising quickly in various European nations. According to a 2018 Ageing Report released by the European Union, the total population of the EU is projected to increase to 520 million in 2070. Yet the number of people in the working-age group (those between the ages of 15 and 64) will decline. Since aged individuals have a greater probability of experiencing orthopedic problems, the demand for foot and ankle devices will increase over the next years. Therefore, the high incidence of road accidents, the high prevalence of diabetes, and the aging population have resulted in an increased need for orthopedic support systems, ensuring the market’s growth in the coming years.
The Germany market dominated the Europe Bone Void Fillers Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $381.9 million by 2030. The UK market is experiencing a CAGR of 6.6% during (2023 - 2030). Additionally, The France market would witness a CAGR of 8.3% during (2023 - 2030).
Based on Type, the market is segmented into Demineralized Bone Matrix, Calcium phosphate Bone Graft Substitute, Collagen Matrix and Others. Based on Form, the market is segmented into Gel & Putty, Granules and Others. Based on Application, the market is segmented into Bone Fracture, Spine Fusion and Others. Based on End User, the market is segmented into Hospital, Specialty Clinics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, DePuy Synthes (Johnson & Johnson), Orthofix Medical, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, NuVasive, Inc., Baxter International, Inc., Biocomposites Ltd., and Arthrex, Inc.
Scope of the Study
Market Segments covered in the Report:
By Type

  • Demineralized Bone Matrix
  • Calcium phosphate Bone Graft Substitute
  • Collagen Matrix
  • Others


By Form

  • Gel & Putty
  • Granules
  • Others


By Application

  • Bone Fracture
  • Spine Fusion
  • Others


By End User

  • Hospital
  • Specialty Clinics
  • Others


By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe


Companies Profiled

  • Medtronic PLC
  • DePuy Synthes (Johnson & Johnson)
  • Orthofix Medical, Inc.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
  • Smith & Nephew PLC
  • NuVasive, Inc.
  • Baxter International, Inc.
  • Biocomposites Ltd.
  • Arthrex, Inc.


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free